METHODS: In 2014, data were collected from a 1% sample of reports made to the FDA from 2000-2014 regarding mesh for POP and SUI. The data included manufacturer, device, reporter, complainant diagnosis, and adverse events. The same 1% sample was reviewed again using the same methods in June of 2018 and edits made to each entry were analyzed.
INTRODUCTION AND OBJECTIVES:
The need for long-term follow up data in female patients undergoing surgery for stress urinary incontinence (SUI) has been repeatedly highlighted by Cochrane reviews and the FDA. This is especially relevant in the current climate of controversy over the safety of mesh-related products. We aimed to assess the subjective long-term outcomes of patients who had undergone SUI surgery at our institution in this real-world study.
METHODS: All female patients who underwent SUI surgery at one institution from January 2011 to December 2016 were identified and sent a 5-item self-administered postal questionnaire. Results were analysed using GraphPad Prism 6.0.
RESULTS: Questionnaires were returned by 364 of 570 patients identified (64% response rate), with a median age of 51 (range 17e84) and mean follow up of 54 months. The majority of respondents underwent TOT insertion (79%), followed by TVT (17%), autologous sling (2%) and Burch colposuspension (2%). 94% of procedures were primary (6% revision). Two-thirds underwent pre-procedure urodynamics. 63/364 (17%) were identified to have a concurrent pelvic organ prolapse (POP) and were treated surgically if symptomatic.
69% of patients described their SUI as much or very much better (73% TOT, 53% TVT). A significantly greater proportion of patients undergoing TVT insertion did so as revision surgery when compared to TOT insertion (p[0.0037). Overall, 55% described an improvement/cure in their overactive bladder symptoms, while 8% said they were worse. A quarter complained of new voiding difficulty (23% TOT, 27% TVT), with 9% requiring intermittent self-catheterisation. 52% declared no post-operative problems, with the remainder reporting UTI (20%), dyspareunia (13%), pelvic pain (12%) and new POP (5%). Ultimately, 7% stated that they had required further surgery, the majority of which was for recurrent SUI. Specifically, 0.8% (3/364) required surgery for tape erosion (all vaginal).
CONCLUSIONS: This study is one of the largest cohorts to report patient-centred real-world outcomes with over 4 year follow up. Our results demonstrate a wane in efficacy of surgery over time, while quantifying the longer-term incidence of complications and the need for further surgery. All surgeons performing surgical procedures for SUI should audit their long-term outcomes in order to accurately counsel patients considering SUI surgery and aid in their decisionmaking.
Source of Funding: None

PD06-04 IMPACT OF FELLOWSHIP TRAINING ON HOSPITAL DISCHARGE DATA FOR WOMEN UNDERGOING URINARY INCONTINENCE PROCEDURESa
Garrett Smith*, Natasha Ginzburg, Syracuse, NY INTRODUCTION AND OBJECTIVES: Urinary incontinence is a prevalent condition that is becoming recognized in more women regardless of the presence of traditional risk factors. Female Pelvic Medicine & Reconstructive Surgery (FPMRS) is a subspecialty of urologists and gynecologists with expertise in the management of pelvic floor disorders, including refractory incontinence. We hypothesized that patients hospitalized after incontinence procedures would have different characteristics based on the level of training of their surgeon. FPMRS surgeons may treat more complex patients in metropolitan areas, and this may be associated with higher costs and length of hospitalization.
METHODS: New York State Statewide Planning and Research Cooperative System (SPARCS) inpatient de-identified datasets were queried for women who underwent genitourinary incontinence procedures from 2009 to 2016. Descriptive statistics using chi-square tests were performed to compare FPMRS-trained surgeons to non-FPMRS surgeons. Age, race, length-of-stay (LOS), hospital service area, and cost were assessed, as was All Patient Refined severity of illness (classified as major, moderate, mild), which calculates the impact of comorbid diseases on a patient's overall health.
RESULTS: Patients undergoing incontinence procedures did not differ by age (p[0.545), however they did differ by race (p[0.001), with FPMRS surgeons operating on more black women (10.3%) and fewer white women (67.0%) compared to non-fellowship trained surgeons (8.2%,75.0%). LOS did not differ between groups (p[0.276). Severity of overall patient illness did not differ significantly based on training (p[0.193) , however 31.0% of moderately complex patients were operated on by FPMRS-trained providers compared to 27.6% in the non-FPMRS group. Fellowship-trained surgeons concentrated near large cities, with 68.3% of all incontinence procedures in Manhattan performed by FPMRS-trained surgeons, versus 39.6% in the Finger Lakes region or 4.5% in Western NY, for instance. Finally, cost differed significantly between groups (p[0.000), with 75.1% of non-FPMRS surgeons having total costs under $7,500 versus 53.7% under such cost in the FPMRS-trained group. Insurance payer did not differ by provider type (p[0.157).
CONCLUSIONS: There was a geographical concentration of practice for FPMRS-trained surgeons in metropolitan areas, presumably at academic centers. They treated a more diverse demographic of patients, but insurance type did not differ. Cost was expectedly higher, however this was not influenced by age or reported severity of illness, nor was it explained by longer hospital stays. More work is needed to determine the clinical and economic impact of these data, particularly in regard to patient outcomes and the need for reoperation. Limitations were innate to the database used, as broad diagnosis and procedure codes may not capture differences in the type or complexity of operation (i.e. fascial vs mesh sling). INTRODUCTION AND OBJECTIVES: Stress incontinence surgery is common and was revolutionized by the midurethral sling. In the wake of regulatory warnings, unsubstantiated claims regarding mesh have permeated public discourse. Despite no supporting evidence, concerns continue to exist regarding a link between mesh and malignancy. We sought to evaluate the association between stress incontinence surgery, including transvaginal mesh, and carcinogenesis in a large population-based cohort.
METHODS: A retrospective cohort of adult women who underwent stress incontinence surgery from 1994-2016 in Ontario was captured from the Institute for Clinical Evaluation Sciences database. Women were identified using physician billing codes in Ontario for the different stress incontinence procedures. The primary outcome of interest was the diagnosis of pelvic cancers. These were defined using ICD-9 and ICD-10 billing codes. Pelvic cancers included urological and gynaecological malignancies. The standardized incidence rate (SIR) was calculated as the ratio of the observed number of pelvic cancer cases divided by the age-stratified expected number of pelvic cancer cases based on the Ontario population. Subgroup analyses were performed for individual malignancies and midurethral sling patients. Multivariable logistic regression modeling examined for risk factors of pelvic malignancy.
RESULTS: A total of 120,999 women underwent a procedure for stress incontinence in the form of urethropexy, combined abdominal/ vaginal sling, bulking agent or midurethral sling in Ontario during the study period. Midurethral sling accounted for 63% of procedures performed. Median follow up was 9.3 years ). Expected cancer cases over a total exposure time of 1,221,668 person-years was 1,146. 935 pelvic cancers were observed with a frequency of 0.77%. The SIR for any cancer diagnosis compared to the general population of Ontario was 0.816, 95% CI 0.764-0.870. In patients who underwent a midurethral sling only, the expected number of cancer cases over an exposure time of 562,457 person-years was 576. 479 pelvic cancers were observed with an SIR of 0.831, 95% CI 0.758-0.909. On multivariable analysis, midurethral sling was not associated with an increased risk of pelvic cancer when compared to the other stress incontinence procedures.
CONCLUSIONS: Stress incontinence surgery including the transvaginal implantation of mesh was not associated with an increased risk of pelvic malignancy in a large population-based cohort.
Source of Funding: None
PD06-06 EFFECT OF BARIATRIC SURGERY ON URINARY INCONTINENCE: A SYSTEMATIC REVIEW AND META-ANALYSIS
Yung Lee, James Yu, Hamilton, Canada; Michał Pę dziwiatr, Piotr Major, Krakow, Poland; Ishan Aditya*, Toronto, Canada; Kari Tikkinen, Helsinki, Finland; Yonah Krakowsky, Toronto, Canada; Aristithes Doumouras, Scott Gmora, Mehran Anvari, Dennis Hong, Hamilton, Canada INTRODUCTION AND OBJECTIVES: Obesity is a major risk factor for urinary incontinence (UI). For treating UI in obese patients, current guidelines recommend weight loss through lifestyle interventions. However, the role of sustained weight loss induced by bariatric surgery for the treatment of UI in obese patients remains unclear. We aimed to conduct a systematic review and meta-analysis to critically evaluate the effect of bariatric surgery on UI in obese patients.
METHODS: We searched Medline, EMBASE, CENTRAL, PubMed, and relevant major conference abstracts up to June 2018, including any studies that compared UI status in obese patients before and after bariatric surgery. Primary outcomes were improvement or complete resolution of stress urinary incontinence (SUI) and urgency urinary incontinence (UUI) before and after surgery. Secondary outcomes were validated urinary incontinence questionnaires: urogenital distress inventory (UDI-6), International Consultation on Incontinence Questionnaire (ICIQ), and Incontinence Impact Questionnaire (IIQ) before and after surgery. Pooled estimates were calculated using random-effects or proportions meta-analysis and heterogeneity was quantified using the I2 statistic. Two reviewers independently reviewed the studies, collected data, assessed risk of bias, and conducted Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) to assess quality of evidence.
RESULTS: 35 cohort studies involving a total of 9,250 obese patients (90.8% female) met the inclusion criteria with a median follow up of 15 months after surgery (range, 6 to 60 months). The weighted mean BMI at baseline was 45.7þ/-6.9 kg/m2 and 32.2þ/-5.9 kg/m2 at follow-up, with an relative reduction of 29.7% after bariatric surgery. Bariatric surgery resulted in improvement or resolution of any UI in 58% (95% CI, 50-65%), SUI in 47% (95% CI, 34-60%), and UUI in 37% of patients (95%CI, 15-62%). Moreover, bariatric surgery significantly decreased UDI-6 scores by 14.7 points (95% CI, 9.6-19.7, P<0.001), ICIQ score by 4.5 points (95% CI, 2.9-6.0, P<0.001), and IIQ scores by 5.3 (95% CI, 3.9-6.6, P<0.001) after surgery. Conversely, 3% (95% CI, 0-13%) of patients experienced worsening or new onset of UI after bariatric surgery. All meta-analysed outcomes had high heterogeneity (I2>50%).
CONCLUSIONS: Bariatric surgery leads to improvement or resolution of SUI in half and of UUI in more than one-third of obese patients. Large scale comparative studies are warranted to further examine the benefits and harms of bariatric surgery as treatment for UI.
INTRODUCTION AND OBJECTIVES: Introduction Epidemiological studies have shown that obesity is an independent risk factor for prevalent and incident incontinence. The prevalence of incontinence has been reported to be as high as 60% to 70% among severely obese women.
OBJECTIVE: Determine the urinary incontinence in women with obesity and the effect of bariatric surgery at 3, 6 and 12 months later.
METHODS: Materials and Methods: The present study is observational, analitic, prospective and longitudinal. Obese adult women, who underwent bariatric surgery from May 2017 to February 2018, were included. Performing a bivariate statistical analysis using Chi square and inferential statistics. RESULTS: Results: 67 patients in total, 73.1% had some type of UI, average age 42.7 years, pre-surgical weight 108.3 kg and BMI of 42.7kg / m2 (Table1). Stres UI (55.1%). 73% had UI, stress UI is the most frequent type in 55%. In 65% mild incontinence was present, 30% affecting their quality of life.
